BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17680883)

  • 1. Oestrogen regulates the expression and function of dopamine transporters in astrocytes of the nigrostriatal system.
    Karakaya S; Kipp M; Beyer C
    J Neuroendocrinol; 2007 Sep; 19(9):682-90. PubMed ID: 17680883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition.
    McArthur S; Murray HE; Dhankot A; Dexter DT; Gillies GE
    J Neurochem; 2007 Feb; 100(3):678-92. PubMed ID: 17116232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related changes in nigrostriatal dopaminergic function in heterozygous mutant dopamine transporter knock-out mice.
    Dluzen DE; Ji J; McDermott JL
    Neurosci Lett; 2010 May; 476(2):66-9. PubMed ID: 20382201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease.
    Afonso-Oramas D; Cruz-Muros I; Alvarez de la Rosa D; Abreu P; Giráldez T; Castro-Hernández J; Salas-Hernández J; Lanciego JL; Rodríguez M; González-Hernández T
    Neurobiol Dis; 2009 Dec; 36(3):494-508. PubMed ID: 19766189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons.
    González-Hernández T; Barroso-Chinea P; De La Cruz Muros I; Del Mar Pérez-Delgado M; Rodríguez M
    J Comp Neurol; 2004 Nov; 479(2):198-215. PubMed ID: 15452855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alteration in the dopamine transporter differentially affects male and female nigrostriatal transporter systems.
    Ji J; Bourque M; Di Paolo T; Dluzen DE
    Biochem Pharmacol; 2009 Dec; 78(11):1401-11. PubMed ID: 19615345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nigrostriatal cell firing action on the dopamine transporter.
    Rodriguez M; Gonzalez S; Morales I; Sabate M; Gonzalez-Hernandez T; Gonzalez-Mora JL
    Eur J Neurosci; 2007 May; 25(9):2755-65. PubMed ID: 17561841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
    Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
    Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BDNF-dependent stimulation of dopamine D5 receptor expression in developing striatal astrocytes involves PI3-kinase signaling.
    Brito V; Beyer C; Küppers E
    Glia; 2004 May; 46(3):284-95. PubMed ID: 15048851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum.
    Singh S; Singh K; Gupta SP; Patel DK; Singh VK; Singh RK; Singh MP
    Brain Res; 2009 Aug; 1283():115-26. PubMed ID: 19520064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of oestrogenic compounds on monoamine transporters in rat striatum.
    Le Saux M; Di Paolo T
    J Neuroendocrinol; 2006 Jan; 18(1):25-32. PubMed ID: 16451217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
    Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
    Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogen and progesterone reduce lipopolysaccharide-induced expression of tumour necrosis factor-alpha and interleukin-18 in midbrain astrocytes.
    Kipp M; Karakaya S; Johann S; Kampmann E; Mey J; Beyer C
    J Neuroendocrinol; 2007 Oct; 19(10):819-22. PubMed ID: 17850464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogen influences on mitochondrial gene expression and respiratory chain activity in cortical and mesencephalic astrocytes.
    Araújo GW; Beyer C; Arnold S
    J Neuroendocrinol; 2008 Jul; 20(7):930-41. PubMed ID: 18445124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter.
    Wersinger C; Sidhu A
    Biochemistry; 2005 Oct; 44(41):13612-24. PubMed ID: 16216085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AQP4 expression in striatal primary cultures is regulated by dopamine--implications for proliferation of astrocytes.
    Küppers E; Gleiser C; Brito V; Wachter B; Pauly T; Hirt B; Grissmer S
    Eur J Neurosci; 2008 Dec; 28(11):2173-82. PubMed ID: 19046364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.
    Bourque M; Liu B; Dluzen DE; Di Paolo T
    Biochem Pharmacol; 2007 Nov; 74(9):1413-23. PubMed ID: 17825264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture.
    Yamamoto H; Kamegaya E; Hagino Y; Imai K; Fujikawa A; Tamura K; Enokiya T; Yamamoto T; Takeshima T; Koga H; Uhl GR; Ikeda K; Sora I
    Neurochem Int; 2007; 51(2-4):237-44. PubMed ID: 17664021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression and capacity of the striatal high-affinity choline transporter in hyperdopaminergic mice.
    Parikh V; Apparsundaram S; Kozak R; Richards JB; Sarter M
    Neuroscience; 2006 Aug; 141(1):379-89. PubMed ID: 16675138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astroglial dopamine transport is mediated by norepinephrine transporter.
    Takeda H; Inazu M; Matsumiya T
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):620-3. PubMed ID: 12444505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.